We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Nuvo

News List

Miravo Healthcare Ireland Enters into Suvexx License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea firstwordpharma
July 30, 2021
Nuvo today announced that its wholly owned subsidiary, Nuvo Pharmaceuticals (Ireland) DAC trading as Miravo Healthcare ("Miravo Ireland"), has entered into an exclusive license and supply agreement (the "License Agreement") with SK Chemicals Co., Ltd.
Nuvo Declared Winning Bidder to Acquire Commercial Products from Aralez americanpharmaceuticalreview
December 03, 2018
Nuvo Pharmaceuticals has been informed by Aralez Pharmaceuticals that Nuvo's previously announced acquisition of Aralez's Canadian business and the Vimovo royalty stream ......
Nuvo Pharmaceuticals acquires global product rights to Resultz® pharmaasia
January 05, 2018
Nuvo Pharmaceuticals Inc.has announced its acquisition of the global, ex-U.S.rights to Resultz® from Piedmont Pharmaceuticals LLC.
Nuvo Announces Results from European Ankle Sprain Study with Pennsaid 2% americanpharmaceuticalreview
May 16, 2017
Nuvo Pharmaceuticals reported topline results from its multi-center, randomized, placebo-controlled, double-blind, parallel group trial in patients, with grade I or II ankle sprains and in particular reported that the Trial had failed to meet its primary